Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis.

Jindani A, Atwine D, Grint D, Bah B, Adams J, Ticona ER, Shrestha B, Agizew T, Hamid S, Jamil B, Byamukama A, Kananura K, Mugisha Taremwa I, Bonnet M, Camara LM, Bah-Sow OY, Bah KS, Bah NM, Sow M, Ticona Huaroto CE, Mugruza Pineda R, Tandukar B, Raya BB, Shrestha N, Mathoma A, Mathebula-Modongo UP, Basotli J, Irfan M, Begum D, Muzammil A, Ahmed I, Hasan R, Burgos MV, Sultan F, Hassan M, Masood I, Robb C, Decker J, Grubnic S, Butcher PD, Witney A, Dhillon J, Munshi T, Fielding K, Harrison TS

Open source

DOI: 10.1056/evidoa2300054
Published: 2023 Sep
Container: NEJM evidence
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/evidoa2300054,
  title = {Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis.},
  author = {Jindani A and Atwine D and Grint D and Bah B and Adams J and Ticona ER and Shrestha B and Agizew T and Hamid S and Jamil B and Byamukama A and Kananura K and Mugisha Taremwa I and Bonnet M and Camara LM and Bah-Sow OY and Bah KS and Bah NM and Sow M and Ticona Huaroto CE and Mugruza Pineda R and Tandukar B and Raya BB and Shrestha N and Mathoma A and Mathebula-Modongo UP and Basotli J and Irfan M and Begum D and Muzammil A and Ahmed I and Hasan R and Burgos MV and Sultan F and Hassan M and Masood I and Robb C and Decker J and Grubnic S and Butcher PD and Witney A and Dhillon J and Munshi T and Fielding K and Harrison TS},
  year = {2023},
  journal = {NEJM evidence},
  doi = {10.1056/evidoa2300054},
  url = {https://doi.org/10.1056/evidoa2300054}
}

RIS

TY  - JOUR
TI  - Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis.
AU  - Jindani A
AU  - Atwine D
AU  - Grint D
AU  - Bah B
AU  - Adams J
AU  - Ticona ER
AU  - Shrestha B
AU  - Agizew T
AU  - Hamid S
AU  - Jamil B
AU  - Byamukama A
AU  - Kananura K
AU  - Mugisha Taremwa I
AU  - Bonnet M
AU  - Camara LM
AU  - Bah-Sow OY
AU  - Bah KS
AU  - Bah NM
AU  - Sow M
AU  - Ticona Huaroto CE
AU  - Mugruza Pineda R
AU  - Tandukar B
AU  - Raya BB
AU  - Shrestha N
AU  - Mathoma A
AU  - Mathebula-Modongo UP
AU  - Basotli J
AU  - Irfan M
AU  - Begum D
AU  - Muzammil A
AU  - Ahmed I
AU  - Hasan R
AU  - Burgos MV
AU  - Sultan F
AU  - Hassan M
AU  - Masood I
AU  - Robb C
AU  - Decker J
AU  - Grubnic S
AU  - Butcher PD
AU  - Witney A
AU  - Dhillon J
AU  - Munshi T
AU  - Fielding K
AU  - Harrison TS
PY  - 2023
JO  - NEJM evidence
DO  - 10.1056/evidoa2300054
UR  - https://doi.org/10.1056/evidoa2300054
ER  -

APA

A, J., D, A., D, G., B, B., J, A., ER, T., B, S., T, A., S, H., B, J., A, B., K, K., I, M. T., M, B., LM, C., OY, B., KS, B., NM, B., M, S., CE, T. H., R, M. P., B, T., BB, R., N, S., A, M., UP, M., J, B., M, I., D, B., A, M., I, A., R, H., MV, B., F, S., M, H., I, M., C, R., J, D., S, G., PD, B., A, W., J, D., T, M., K, F., & TS, H. (2023). Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis.. NEJM evidence. https://doi.org/10.1056/evidoa2300054

Source records

pubmed · retrieved 2026-09-25T16:38:03.685Z